secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensus Healthcare, Inc. (SRTS)
CIK:        0001494891
Form:       8-K
Filed at:   2024-11-18T23:59:59+00:00
Accession:  0001213900-24-099516
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sensus Q3 revenues double to $8.8M; net income $1.2M vs loss; targets >50 IG-SRT deals by year-end
--------------------------------------------------------------------------------

- Revenue $8.8M (+127% YoY); net income $1.2M ($0.07 diluted EPS) vs net loss $1.5M ($0.09 loss) in Q3 2023.
- Adjusted EBITDA $1.6M vs negative $1.7M; shipped 27 systems (11 in Q3 2023).
- Signed 22 IG-SRT units under Fair Deal as of Sep 30; expects >50 by year-end, generating recurring revenue in 2025.
- Cash $22.6M, no debt; gross margin improved to 59.3% from 51.0%.
- Sold SRT system to Providence Swedish Hospital; strong interest at ASTRO conference.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1494891/000121390024099516/0001213900-24-099516-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1494891/000121390024099516/ea0221591-8k_sensus.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-099516

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer